| Identification | Back Directory | [Name]
2-Hexadecanol, 1,1′-[[3-[4-[2-[[3-[bis(2-hydroxyhexadecyl)amino]-2-ethoxypropyl](2-hydroxyhexadecyl)amino]ethyl]-1-piperazinyl]-2-ethoxypropyl]imino]bis- | [CAS]
2639634-93-6 | [Synonyms]
2-Hexadecanol, 1,1′-[[3-[4-[2-[[3-[bis(2-hydroxyhexadecyl)amino]-2-ethoxypropyl](2-hydroxyhexadecyl)amino]ethyl]-1-piperazinyl]-2-ethoxypropyl]imino]bis- | [Molecular Formula]
C96H197N5O7 | [MOL File]
2639634-93-6.mol | [Molecular Weight]
1533.62 |
| Chemical Properties | Back Directory | [Boiling point ]
1196.0±65.0 °C(predicted) | [density ]
0.934±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | [solubility ]
Chloroform: Soluble
Ethanol: Soluble
Methanol: Soluble | [pka]
14.31±0.20(predicted) |
| Hazard Information | Back Directory | [Uses]
Lipid C3 can be used to synthesize lipid-like nanoparticles (LNPs) for delivery of mRNA[1]. | [References]
[1] Miao L, et al. Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver. Nat Commun. 2020 May 15;11(1):2424. DOI:10.1038/s41467-020-16248-y |
|
|